1979
DOI: 10.1136/vr.105.20.469
|View full text |Cite
|
Sign up to set email alerts
|

The financial burden of infectious bovine rhinotracheitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

1983
1983
2000
2000

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…The considerable financial burden due to infectious bovine rhinotracheitis in British fattening cattle was reported by Wiseman and others (1979). Their figures have recently been updated to 1996 prices, using the change in the retail price index between 1977 and 1996 (Gibbs 1996), and have been shown to range from £13 to £146, with a mean cost of £68 per animal at risk.…”
Section: Production Losses and The Economics Of Treatmentmentioning
confidence: 90%
See 1 more Smart Citation
“…The considerable financial burden due to infectious bovine rhinotracheitis in British fattening cattle was reported by Wiseman and others (1979). Their figures have recently been updated to 1996 prices, using the change in the retail price index between 1977 and 1996 (Gibbs 1996), and have been shown to range from £13 to £146, with a mean cost of £68 per animal at risk.…”
Section: Production Losses and The Economics Of Treatmentmentioning
confidence: 90%
“…Knowledge based on sound economics is sparse, and in Europe the cost of clinical respiratory disease has been difficult to quantify accurately. With the exception of one or two examples (Thomas and others 1978, Wiseman and others 1979), most of the data on the morbidity and mortality due to respiratory disease in growing cattle originate from North America. Reviewing the literature on morbidity and mortality in feedlot cattle between 1955 and 1984, Kelly and Janzen (1986) showed that the morbidity ranged up to 69 per cent, and was most commonly between 15 and 45 per cent, and the mortality was up to 15 per cent, and most commonly between 1 and 5 per cent, with the most frequent clinical and postmortem diagnosis being respiratory disease.…”
Section: Production Losses and The Economics Of Treatmentmentioning
confidence: 99%